What does Preamble of HR 7352 do?

This bill aims to amend the Public Health Service Act. The proposed legislation seeks to establish a program focused on developing new antimicrobial drugs. The program's target is to address the most challenging pathogens and threatening infections.

What does SHORT TITLE. of HR 7352 do?

This bill is formally titled the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2026, also known as the PASTEUR Act of 2026.

What does PURPOSE. of HR 7352 do?

This Act aims to ensure the availability of antimicrobials. It intends to stimulate research, development, and market access for lifesaving medicines. The Act seeks to ensure the appropriate use of lifesaving medicines. It aims to maintain high medical care standards for American patients. The Act promotes national health system preparedness. It also intends to defend the United States and its military.

What does DEVELOPING ANTIMICROBIAL INNOVATIONS. of HR 7352 do?

This section amends the Public Health Service Act to establish U.S. Novel Antimicrobial Supply Contracts. The Secretary may enter into contracts with sponsors of eligible antimicrobials to ensure their availability. Eligible antimicrobials must treat pathogens identified as urgent or serious threats by the CDC or deemed appropriate by the Secretary in consultation with an advisory group. Sponsors must submit applications to the Secretary within two years of the antimicrobial's approval or licensure. Applications must include information to determine the antimicrobial’s score based on a methodology established by the Secretary. The Secretary will review applications and deny those with scores below a minimum threshold, or approve and calculate payments for those that meet or exceed the threshold. The Secretary is required to establish a scoring methodology and minimum scoring threshold within 270 days of the part’s enactment. The scoring methodology will consider contributions to patient care, innovative characteristics, and benefits to health systems and public health. The bill authorizes $6,000,000,000 for fiscal year 2026 to carry out this part.

Back to bills

PASTEUR Act of 2026 — HR. 7352

Last updated: 2/4/2026 · Introduced: 2/4/2026

Author: Earl Carter (R-GA)

TL;DR (AI)

The PASTEUR Act establishes U.S. Novel Antimicrobial Supply Contracts, allowing the Secretary to enter into agreements with antimicrobial sponsors to ensure availability of drugs targeting urgent or serious threats.
The bill authorizes $6 billion for fiscal year 2026 to support the development and availability of new antimicrobial drugs.
The Act establishes a scoring methodology to evaluate antimicrobials based on patient care contributions, innovative characteristics, and benefits to health systems and public health.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 2 more.

4 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account